Celavi Trio Tablet (15) is a prescription drug, available for use as Tablet. The alternative uses of Celavi Trio Tablet (15) have also been explained below.
The optimal dosage of Celavi Trio Tablet (15) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Celavi Trio Tablet (15) also has some side effects, the most common being Upper respiratory tract infection, Loss of appetite, Gastric Irritation. Besides the aforementioned side effects, there are other adverse effects of Celavi Trio Tablet (15) as well, which are listed below. Such side effects of Celavi Trio Tablet (15) normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Celavi Trio Tablet (15) is Mild for pregnant women and Mild for women who are breastfeeding. In addition, Celavi Trio Tablet (15)'s effects on the liver, heart and kidney are discussed below in the Celavi Trio Tablet (15) related warnings section.
Celavi Trio Tablet (15) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) are examples of such conditions. Other conditions have been mentioned below in the Celavi Trio Tablet (15) contraindications section.
Additionally, Celavi Trio Tablet (15) may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Celavi Trio Tablet (15) is considered not safe while driving, and is not addictive.
Celavi Trio Tablet (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Celavi Trio Tablet (15) safe for pregnant women?
Celavi Trio has mild to no side effects in pregnant women.
Is the use of Celavi Trio Tablet (15) safe during breastfeeding?
Side effects of Celavi Trio for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Celavi Trio Tablet (15) on the Kidneys?
Celavi Trio may have mild side effects on the kidneys.
What is the effect of Celavi Trio Tablet (15) on the Liver?
Celavi Trio has very mild side effects on the liver.
What is the effect of Celavi Trio Tablet (15) on the Heart?
Side effects of Celavi Trio rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Celavi Trio Tablet (15) unless your doctor advises you to do so -
Is this Celavi Trio Tablet (15) habit forming or addictive?
Celavi Trio Tablet (15) is not addictive in nature.
Interaction between Food and Celavi Trio Tablet (15)
Some foods when eaten with Celavi Trio Tablet (15) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Celavi Trio Tablet (15)
Consuming Celavi Trio Tablet (15) with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448